期刊文献+

复合细胞和人工骨的富血小板血浆成骨能力研究 被引量:9

OSTEOGENIC POTENTIAL OF PLATELET-RICH PLASMA COMBINED WITH CELLS AND ARTIFICIAL BONE
暂未订购
导出
摘要 目的探讨复合细胞和人工骨的富血小板血浆(platelet-richplasma,PRP)促进骨缺损修复的能力。方法取新西兰大白兔骨髓,分离培养骨髓基质干细胞(marrowstromalstemcells,MSCs);取兔全血体外诱导培养为类成骨样细胞,应用低密度两次离心法制备PRP。取48只1岁左右新西兰大白兔建立双侧桡骨1.2cm骨缺损模型,根据缺损中植入材料的不同随机分为4组,每组12只。A组左侧PRP/MSCs/β-磷酸三钙(β-tricalciumphosphate,β-TCP),右侧MSCs/β-TCP;B组左侧自体骨,右侧PRP/MSCs/β-TCP;C组左侧自体骨,右侧MSCs/β-TCP;D组左侧PRP/β-TCP,右侧β-TCP。术后2、6及12周通过大体观察、X线片、组织学及生物力学观察桡骨缺损的愈合情况。结果制备的PRP血小板浓度稳定,约为全血的5.45±0.23倍。大体标本与X线片显示2、6周时PRP/MSCs/β-TCP在缺损处桥接及新生骨外形较自体骨差,与MSCs/β-TCP无明显区别;12周,PRP/MSCs/β-TCP在缺损处桥接及新生骨外形接近于自体骨,优于MSCs/β-TCP。组织学观察,在新生骨数量及成熟度方面,术后各时间点PRP/MSCs/β-TCP明显优于MSCs/β-TCP(P<0.05),PRP/MSCs/β-TCP与自体骨无差异(P>0.05);2、6周PRP/β-TCP与β-TCP无差异(P>0.05);12周PRP/β-TCP优于β-TCP(P<0.05)。新生骨生物力学强度检测,6、12周PRP/MSCs/β-TCP优于MSCs/β-TCP(P<0.05);6周PRP/MSCs/β-TCP小于自体骨(P<0.05),但12周与自体骨无差异(P>0.05);12周PRP/β-TCP与β-TCP无差异(P>0.05)。结论PRP复合MSCs和β-TCP显示出了良好的成骨能力,PRP可通过提高MSCs和成骨细胞的增殖与分化活性,促进骨缺损的修复。 Objective To investigate the ability of platelet-rich plasma(PRP) combined with cells and artificial bone in accelerating the repair of bone defect. Methods The marrow stromal stem cells (MSCs) of rabbit were cultured and induced into the osteoblast-like cells in vitro. PRP was produced with low-density twice centrifugations. Forty-eight New Zealand rabbits were made 1.2 cm bilateral radius defect models and divided into 4 groups averagely at random: group A (left : PRP/MSCs/β-tricalcium phosphate (β-TCP), right : MSCs/β-TCP), group B (left : auto-radius, right : PRP/MSCs/β-TCP); group C (left:auto-radius, right: MSCs/β-TCP), and group D(Ieft..PRP/β-TCP; right:β-TCP). At 2, 6 and 12 weeks after operation, the repair of bone defect was evaluated by the general observation, histology, biomechanics and histomorphology. Results There was a stable platelet concentration in PRP and it was about 5.45± 0. 23 times of whole blood. In the aspect of bone bridge and conture of the defects, at 2 and 6 weeks, PRP/MSCs/ β-TCP and MSCs/β-TCP displayed a similar outcome and were less than auto in general sample and X-ray ;at 12 weeks, PRP/MSCs/β-TCP was similar to auto-radius and better than MSCs/β-TCP. in the aspect of quantity and quality of bone formation,histology showed that PRP/MSCs/β-TCP and auto-radius were better than MSCs/β-TCP (P〈 0. 05), and there was no significant difference between PRP/MSCs/β-TCP and auto-radius (P〉0. 05). At 2 and 6 weeks,there was no significant difference between PRP/β-TCP and β-TCP(P〉0. 05)o At 12 weeks,PRP/β-TCP was better than β-TCP (P〈0. 05). In the aspect of intensity of bone formation,at 6 and 12 weeks,PRP/MSCs/β-TCP and auto-radius were better than MSCs/β-TCP(P〈0. 05). At 6 weeks,auto-radius was better than PRP/MSCs/β-TCP(P〈0. 05). At 12 weeks,there was no significant difference between PRP/MSCs/β-TCP and auto(P〉0. 05). PRP/TCP and β-TCP had no significant difference at 12 weeks (P〉 0. 05). Conclusion PRP/MSCs/β-TCP demonstrated excellent ability of forming bone in experiment. PRP was most likely to accelerate the repair of bone defect through increasing the activity of proliferation and differentiation of MSCs and osteoblasts.
出处 《中国修复重建外科杂志》 CAS CSCD 北大核心 2007年第1期58-64,共7页 Chinese Journal of Reparative and Reconstructive Surgery
基金 国家自然科学基金资助项目(30471747)~~
关键词 富血小板血浆 骨髓基质干细胞 Β-磷酸三钙 骨缺损 修复 Platelet-rich plasma Marrow stromal stem ceils β-tricalcium phosphate Bone defect Repair
  • 相关文献

参考文献18

  • 1Eppley BL,Woodell JE,Higgins J.Platelet quantification and growth factor analysis from platelet-rich plasma:implications for wound healing.Plast Reconstr Surg,2004,114(6):1502-1508.
  • 2Fennis JP,Stoelinga PJ,Jansen JA.Mandibular reconstruction:a histological and histomorphometric study on the use of autogenous scaffolds,particulate cortico-cancellous bone grafts and platelet rich plasma in goats.Int J Oral Maxillofac Surg,2004,33(1):48-55.
  • 3Kovacs K,Velich N,Huszar T,et al.Comparative study of beta-tricalcium phosphate mixed with platelet-rich plasma versus beta-tricalcium phosphate,a bone substitute material in dentistry.Acta Vet Hung,2003,51(4):475-484.
  • 4张长青,袁霆,曾炳芳,陶海荣,邵雷,徐铮宇,宋文奇,张晔,朱珍宏,眭述平.富血小板血浆促进骨缺损修复的实验研究[J].中国修复重建外科杂志,2003,17(5):355-358. 被引量:49
  • 5Kassolis JD,Reynolds MA.Evaluation of the adjunctive benefits of platelet-rich plasma in subantral sinus augmentation.J Craniofac Surg,2005,16(2):280-287.
  • 6Wiltfang J,Kloss FR,Kessler P,et al.Effects of platelet-rich plasma on bone healing in combination with autogenous bone and bone substitutes in critical-size defects.An animal experiment.Clin Oral Impl Res,2004,15(2):187-193.
  • 7Marx RE.Platelet-rich plasma:evidence to support its use.J Oral Maxillofac Surg,2004,62(4):489-496.
  • 8Weibrich G,Hansen T,Kleis W,et al.Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration.Bone,2004,34(4):665-671.
  • 9Landesberg R,Roy M,Glichman RS.Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation.J Oral Maxillofac Surg,2000,58(3):297-300.
  • 10Okuda K,Kawase T,Momose M,et al.Platelet-rich plasma contains high levels of platelet-derived growth factor and transforming growth factor-beta and modulates the proliferation of periodontally related cells in vitro.J Periodontol,2003,74(6):849-857.

二级参考文献21

  • 1Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants, 1999,14(4):529.
  • 2Fennis JP, Stoelinga PJ, Jansen JA. Mandibular reconstruction:a clinical and radiographic animal study on the use of autogenous scaffolds and platelet-rich plasma. Int J Oral Maxillofac Surg,2002;31(3) :281.
  • 3Froum SJ, Wallace SS, Tarnow DP,et al. Effect of platelet-rich plasma on bone growth and ossteointegration in human maxillary sinus grafts: Three bilateral case reports. Int J Periodontics Restorative Dent, 2002,22(1):45.
  • 4Tischler M. Platelet rich plasma. The use of autologous growth factors to enhance bone and soft tissue grafts. NY State Dent J,2002,68(3) : 22.
  • 5Tayapongsak P, O Brlnen DA, Monteiro CB, et al. Autologous fibrin adhesive in mandibular reconstruction with particulate cancellous bone and marrow. J Oral Maxillofac Surg, 1994,52(2):161.
  • 6Miyazono K, Ten-Dijke P, Ichiyo H, et al. Receptors for transforming growth factor-beta. Adv Immunol, 1994,15(11):181.
  • 7Whitman DH, Berry RL, Green DM. Platelet gel:an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg, 1997; 55(11): 1 294.
  • 8Obarrio JJ, Arauz-Dutari JI, Chamberlain TM, et al. The use of autologous growth factors in periodontal surgical therapy: Platelet gel biotechnology-case reports.Int J Periodontics Restorative Dent,2000,20(5) 5486.
  • 9Soory M, Virdi H. Implications of minocycline, platelet-derived growth factor, and transforming growth factor-beta on inflammatory repair potential in the periodontium. J Periodontol, 1999,70(10);1 136.
  • 10Marx RE, Carlson ER, Eichstaedt RM, et al. Platelet-rich plasma. Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod,1998,85(6):638.

共引文献73

同被引文献162

引证文献9

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部